Success Metrics

Clinical Success Rate
94.4%

Based on 17 completed trials

Completion Rate
94%(17/18)
Active Trials
0(0%)
Results Posted
53%(9 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_3
3
14%
Ph not_applicable
8
36%
Ph phase_4
9
41%
Ph phase_2
1
5%

Phase Distribution

0

Early Stage

1

Mid Stage

12

Late Stage

Phase Distribution21 total trials
Phase 2Efficacy & side effects
1(4.8%)
Phase 3Large-scale testing
3(14.3%)
Phase 4Post-market surveillance
9(42.9%)
N/ANon-phased studies
8(38.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

89.5%

17 of 19 finished

Non-Completion Rate

10.5%

2 ended early

Currently Active

0

trials recruiting

Total Trials

22

all time

Status Distribution
Active(1)
Completed(17)
Terminated(2)
Other(2)

Detailed Status

Completed17
Terminated1
Withdrawn1
unknown1
Suspended1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
0
Success Rate
94.4%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (4.8%)
Phase 33 (14.3%)
Phase 49 (42.9%)
N/A8 (38.1%)

Trials by Status

terminated15%
withdrawn15%
unknown15%
completed1777%
suspended15%
not_yet_recruiting15%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT06709066Not Applicable

Muscle Relaxant Effect and Safety of Mivacurium Chloride and Succinylcholine for Bronchoscopy

Not Yet Recruiting
NCT02822144Phase 3

General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke

Completed
NCT05556408Phase 4

High-Resolution Solid-State Manometry of the Effect of Succinylcholine on Barrier Pressure

Completed
NCT02914119

Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals

Completed
NCT00474253Phase 3

Comparison of Recovery From Rocuronium 1.2 mg/kg Followed by Sugammadex (Org 25969) 16 mg/kg at 3 Minutes With Recovery From Succinylcholine 1.0 mg/kg (19.4.303)(P05946)(MK-8616-026)

Completed
NCT01941628Phase 4

Comparison of Surgical Conditions in Cesarean Section Under General Anesthesia With Deep Neuromuscular Blockade Versus Succinylcholine

Completed
NCT02635542Phase 4

Effect of Neuromuscular Blockade on Pulmonary Complications in Elective Cardiac Surgery

Completed
NCT03469323Not Applicable

Effects of Succinylcholine on Nonintubated Thoracoscopic Surgery

Unknown
NCT02425449Phase 4

Fade Upon TOF Stimulation Induced by Succinylcholine

Completed
NCT01996358Not Applicable

Comparing Intubating Conditions Using Succinylcholine or Rocuronium for Rigid Bronchoscopy

Suspended
NCT01579864Phase 4

Succinylcholine or Rocuronium for Rigid Bronchoscopy Under General Anesthesia

Terminated
NCT00986583Not Applicable

Effect of Succinylcholine on Patients Using Statins

Completed
NCT02667353Not Applicable

Neurorestorative Effects of Electroconvulsive Therapy (ECT) in Patients With Severe Late Life Depression

Completed
NCT01571908Phase 2

Rapid Sequence Intubation With Magnesium-rocuronium Compared With Succinylcholine - A Randomised Clinical Study

Completed
NCT02410590Phase 4

Rocuronium + Sugammadex vs. Succinylcholine + Cisatracurium + Neostigmine/Atropine in Obese Participants (MK-8616-104)

Withdrawn
NCT00751179Phase 3

Rocuronium Plus Sugammadex Versus Succinylcholine Alone in Participants Undergoing Short Surgical Procedures (19.4.319)(P05700 AM2)(COMPLETED)

Completed
NCT01441960Not Applicable

Optimal Dose of Succinylcholine and Rocuronium for Electroconvulsive Therapy (ECT)

Completed
NCT02237443Phase 4

Mask Ventilation Before and After Neuromuscular Blockade

Completed
NCT01966484Not Applicable

Low Dose Mivacurium vs. Low Dose Succinylcholine for Rigid Bronchoscopy

Completed
NCT01902641Not Applicable

Muscle Relaxation for Short Procedures

Completed

Drug Details

Intervention Type
DRUG
Total Trials
22